Sorry, you need to enable JavaScript to visit this website.

COVID-19 mRNA Vaccine BNT162b2

This medicinal product does not have a UK marketing authorisation but has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency for active immunization to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 16 years of age and over.

As with any new medicine in the UK, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Please click on the question above to see related content

How can I order the vaccine?

COVID-19 mRNA Vaccine BNT162b2 is a Prescription only medicine which has been centrally procured by the UK government and is not currently available to buy direct from Pfizer at this time. Public Health England has advised that COVID-19 vaccines for those authorised by the NHS to deliver the COVID-19 vaccination programme will be made available for ordering on the ImmForm website https://portal.immform.phe.gov.uk/ telephone 0207 183 8580.* Arrangements in Scotland, Wales and Northern Ireland may be different, please contact Public Health Agencies in each respective administration for local details.

*Reference: Public Health England. Immunisation against infectious disease. The Green Book, Chapter 14a: COVID-19. Published: 5th December 2020. Available at: https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a. Accessed December 2020.

How do I prepare and administer the vaccine?

The COVID-19 mRNA Vaccine BNT162b2 Reg 174 Information for UK Healthcare Professionals states the following in Section 4.2 Posology and method of administration:

Method of administration

Administer the COVID-19 mRNA Vaccine BNT162b2 vaccine intramuscularly in the deltoid muscle after dilution.

Do not inject the vaccine intravascularly, subcutaneously or intradermally.

Preparation: The multidose vial is stored frozen and must be thawed prior to dilution.

Further detailed information on the preparation of the vaccine can be found in Section 4.2 of the COVID-19 mRNA Vaccine BNT162b2 Reg 174 Information for UK Healthcare Professionals.

Alternatively, for further information on this topic please use the search function above.